Gracell Biotechnologies Announces Up to $150 Million Private Placement Financing Joined by Syndicate of Premier Healthcare Investors

Hong Kong – August 9, 2023 – Cooley advised Gracell Biotechnologies, a global clinical-stage biopharmaceutical company dedicated to developing innovative and highly efficacious cell therapies for the treatment of cancer and autoimmune diseases, on its private placement financing of up to $150 million. Partners Will Cai and Jie Zhang led the Cooley team advising Gracell.

Joined by a syndicate of premier healthcare investors, the private placement financing consisted of 138,900,000 ordinary shares – which is equivalent to 27,780,000 of Gracell’s American depositary shares (ADSs) priced at $3.60 per ADS – for a total of $100 million. The investors also will have an option to purchase up to 44,802,870 ordinary shares (equivalent to 8,960,574 ADSs) at an exercise price equivalent to $5.58 each, for a total of $50 million, within 24 months after the close of the private placement. Gracell will use proceeds from the financing to promote research and development of its clinical-stage product candidates and research programs, as well as for working capital and other general corporate purposes.

Cooley previously advised Gracell on its $209 million initial public offering in January 2021 and its $100 million Series C in October 2020.

About Cooley LLP

Clients partner with Cooley on transformative deals, complex IP and regulatory matters, and high-stakes litigation, where innovation meets the law.

Cooley has nearly 1,400 lawyers across 18 offices in the United States, Asia and Europe, and a total workforce of more than 3,000.

This content is provided for general informational purposes only, and your access or use of the content does not create an attorney-client relationship between you or your organization and Cooley LLP, Cooley (UK) LLP, or any other affiliated practice or entity (collectively referred to as “Cooley”). By accessing this content, you agree that the information provided does not constitute legal or other professional advice. This content is not a substitute for obtaining legal advice from a qualified attorney licensed in your jurisdiction and you should not act or refrain from acting based on this content. This content may be changed without notice. It is not guaranteed to be complete, correct or up to date, and it may not reflect the most current legal developments. Prior results do not guarantee a similar outcome. Do not send any confidential information to Cooley, as we do not have any duty to keep any information you provide to us confidential. This content may be considered Attorney Advertising and is subject to our legal notices.